Robert V Baumgartner Bio Techne Corp (TECH) insider trading activity

Robert V Baumgartner is Director of BIO-TECHNE Corp. Currently has a direct ownership of 46,503 shares of TECH, which is worth approximately $2.76 Million. The most recent transaction as insider was on Oct 30, 2025, when has been sold 1,640 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 46.5K

3.66% 3M change

3.66% 12M change

Total Value Held $2.76 Million

ROBERT V BAUMGARTNER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 30 2025	BUY Grant, award, or other acquisition	-	1,640 Added 3.41%	46,503 Common Stock
Aug 25 2025	SELL Open market or private sale	$957,818 $56.21 p/Share	17,040 Reduced 27.53%	44,863 Common Stock
Aug 25 2025	BUY Exercise of conversion of derivative security	$372,153 $21.84 p/Share	17,040 Added 21.59%	61,903 Common Stock
Oct 24 2024	BUY Grant, award, or other acquisition	-	1,462 Added 3.16%	44,863 Common Stock
Aug 08 2024	SELL Open market or private sale	$1,153,600 $72.1 p/Share	16,000 Reduced 26.94%	43,401 Common Stock
Aug 08 2024	BUY Exercise of conversion of derivative security	$367,200 $22.95 p/Share	16,000 Added 21.22%	59,401 Common Stock
Oct 26 2023	BUY Grant, award, or other acquisition	-	1,625 Added 3.61%	43,401 Common Stock
Oct 27 2022	BUY Grant, award, or other acquisition	-	338 Added 3.13%	10,444 Common Stock
May 10 2022	BUY Open market or private purchase	$105,765 $352.55 p/Share	300 Added 2.88%	10,106 Common Stock
Oct 28 2021	BUY Grant, award, or other acquisition	-	194 Added 1.94%	9,806 Common Stock
Aug 23 2021	SELL Open market or private sale	$1,941,080 $485.27 p/Share	4,000 Reduced 29.39%	9,612 Common Stock
Aug 23 2021	BUY Exercise of conversion of derivative security	$349,560 $87.39 p/Share	4,000 Added 22.71%	13,612 Common Stock
Nov 18 2020	SELL Open market or private sale	$1,516,650 $303.33 p/Share	5,000 Reduced 34.22%	9,612 Common Stock
Nov 18 2020	BUY Exercise of conversion of derivative security	$334,500 $66.9 p/Share	5,000 Added 25.49%	14,612 Common Stock
Oct 29 2020	BUY Grant, award, or other acquisition	-	391 Added 3.91%	9,612 Common Stock

RVB

Robert V Baumgartner

Director

Minneapolis, MN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TECH shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Techne Corp insider buys or sells TECH shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIO-TECHNE Corp

Track Activities on TECH

Account